Electrospherization of genistein@DNA core-shell nanospheres as a drug delivery system and theoretical study of the release mechanism
Source abstract
Abstract
Abstract The practical application of genistein (GEN) as a drug system is hindered by its low aqueous solubility and poor oral bioavailability. Encapsulation of poor water-soluble drug was considered as one of the widely used approaches to overcome such of these obstacles. The primary goal of this research was to in situ encapsulate the hydrophobic GEN during the electrosynthesis of DNA nanospheres as a delivery system (Es GEN@DNA) with appropriate drug release properties. The prepared Es GEN@DNA nanospheres were characterized using UV-visible spectroscopy, X-ray diffraction analysis (XRD), transmission electron microscope (TEM), zeta potential and stability test. The results revealed that GEN was successfully encapsulate in situ during the DNA electrospherization (Es GEN@DNA) as core shell like structure (Core: GEN and Shell: DNA) with a wonderful stability against time. Furthermore, the drug encapsulation % was studied. In addition, the drug release efficiency of Es GEN@DNA was recorded and theoretically visualized to understand the mechanism and kinetics of GEN drug release. %Encapsulation of GEN within DNA nanospheres was found to be 89.62%. Es GEN@DNA release profile explored that the well entrapped GEN within the DNA nanospheres could be a promising for sustained drug release. Besides, we overcome the dilemma of using a fractal or fractional kinetics model by introducing a general fractional kinetic equation that involves a time-dependent rate coefficient, which introduced that the solution of the fractional kinetic model is capable of fitting the release data profiles of free GEN and Es GEN@DNA.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: DNA and Nucleic Acid Chemistry · Advanced biosensing and bioanalysis techniques · Nanopore and Nanochannel Transport Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (72)
Show source-provided references
1. Solid-state characterization and solubility of a genistein–caffeine cocrystal10.1016/j.molstruc.2014.07.036 ↗
2. Soybean soluble polysaccharide enhances absorption of soybean genistein in mice10.1016/j.foodres.2017.10.054 ↗
3. Genistein10.1016/S0031-9422(02)00116-4 ↗
4. Optimization of genistein solubilization by κ-carrageenan hydrogel using response surface methodology10.1016/j.fshw.2013.06.001 ↗
5. Genistein: an integrative overview of its mode of action, pharmacological properties, and health benefits10.1155/2021/3268136 ↗
6. Fabrication of nanostructured mesoporous starch encapsulating soy-derived phytoestrogen (genistein) by well-tuned solvent exchange method10.1016/j.ijbiomac.2020.05.124 ↗
7. Genistein and cancer: current status, challenges, and future directions10.3945/an.114.008052 ↗
8. Genistein: a potential natural lead molecule for new drug design and development for treating memory impairment10.3390/molecules27010265 ↗
9. Synthesis, characterization, and evaluation of genistein-loaded zein/carboxymethyl chitosan nanoparticles with improved water dispersibility, enhanced antioxidant activity, and controlled release property10.3390/foods9111604 ↗
10. Preparation, characterization, and pharmacokinetics study of a novel genistein-loaded mixed micelles system10.1080/03639045.2018.1483384 ↗
11. Regioselective sonochemical synthesis of genistein derivatives10.1016/j.ultsonch.2004.10.002 ↗
12. Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment
13. Solid dispersion of poorly water-soluble drugs: early promises, subsequent problems, and recent breakthroughs10.1021/js980403l ↗
14. Mechanisms enforcing the estrogen receptor beta selectivity of botanical estrogens10.1096/fj.13-234617 ↗
15. Correlation of ZAP-70 expression in B cell leukemias to the ex vivo response to a combination of fludarabine/genistein10.1007/s00262-006-0207-x ↗
16. Gene expression profiles of genistein-treated PC3 prostate cancer cells10.1093/jn/132.12.3623 ↗
17. Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells10.3892/ijo.2013.1946 ↗
18. Genistein inhibits hepatocellular carcinoma cell migration by reversing the epithelial-mesenchymal transition: partial mediation by the transcription factor NFAT110.1002/mc.22100 ↗
19. Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines10.1002/cncr.24250 ↗
20. Soy phytochemicals prevent orthotopic growth and metastasis of bladder cancer in mice by alterations of cancer cell proliferation and apoptosis and tumor angiogenesis10.1158/0008-5472.CAN-05-1332 ↗
21. Genistein induces receptor and mitochondrial pathways and increases apoptosis during BCL-2 knockdown in human malignant neuroblastoma SK-N-DZ cells10.1002/jnr.22244 ↗
22. Genistein induces growth arrest and suppresses telomerase activity in brain tumor cells10.1002/gcc.21979 ↗
23. Genistein-inhibited cancer stem cell-like properties and reduced chemoresistance of gastric cancer10.3390/ijms15033432 ↗
24. Understanding genistein in cancer: the "good" and the "bad" effects: a review10.1016/j.foodchem.2015.09.085 ↗
25. Synthesis and characterisation of chitosan-encapsulated genistein: its anti-proliferative and anti-angiogenic activities10.1080/02652048.2020.1740804 ↗
26. Investigation of transport of genistein, daidzein and their inclusion complexes prepared with different cyclodextrins on Caco-2 cell line10.1016/j.jpba.2013.05.012 ↗
27. Genistein-loaded nanoparticles of star-shaped diblock copolymer mannitol-core PLGA-TPGS for the treatment of liver cancer10.1016/j.msec.2015.10.087 ↗
28. Applications of spherical nucleic acid nanoparticles as delivery systems10.1016/j.molmed.2019.08.012 ↗
29. Microwave assisted green synthesis of Zwitterionic photolumenescent N-doped carbon dots: an efficient ‘on-off’chemosensor for tracer Cr (+ 6) considering the inner filter effect and nano
30. Hyaluronic acid-graphene oxide quantum dots nanoconjugate as dual purpose drug delivery and therapeutic agent in meta-inflammation
31. Tailor made magnetic nanolights: fabrication to cancer theranostics applications
32. Dewan · 2023 · vol. 407
33. Biodegradable and removable implants for controlled drug delivery and release application10.1080/17425247.2022.2110065 ↗
34. Design of magnetic hydrogels for hyperthermia and drug delivery10.3390/polym13234259 ↗
35. S. Ganguly, P. Das, J. Parameswaranpillai, P. Maity, Fluorescent nanomaterials for biomedical, applications 10 1328035.10.3389/fmats.2023.1328035 ↗
36. Light emitting diode irradiation induced shape conversion of DNA-capped silver nanoparticles and their antioxidant and antibacterial activities10.1080/21691401.2018.1439841 ↗
37. Long-range assembly of DNA into nanofibers and highly ordered networks10.1002/wnan.1218 ↗
38. Antibacterial activity of DNA-stabilized silver nanoclusters tuned by oligonucleotide sequence10.1021/acsami.6b00670 ↗
39. Spherical nucleic acids10.1021/ja209351u ↗
40. Controlled formation of hydrophobic surfaces by self-assembly of an amphiphilic natural protein from aqueous solutions10.1039/c3sm50667c ↗
41. Komiyama · 2022
42. Irudayam maria johnson, and raghunathan malathi interaction of resveratrol and genistein with nucleic acids
43. Sonochemical synthesis of DNA nanospheres10.1002/cbic.201100009 ↗
44. DNA metallization: principles, methods, structures, and applications10.1039/C8CS00011E ↗
45. Self-assembled multifunctional DNA nanospheres for biosensing and drug delivery into specific target cells10.1039/C5NR01092F ↗
46. Self-assembled DNA nanowires as quantitative dual-drug nanocarriers for antitumor chemophotodynamic combination therapy10.1039/C7TB01590A ↗
47. The effect of pH on charge inversion and condensation of DNA10.1039/C6SM01344A ↗
48. Anomalous kinetic study of atenolol release from ATN@DNA a core-shell like structure10.1038/s41598-023-29774-8 ↗
49. Generalized fractional diffusion equation with arbitrary time varying diffusivity
50. Novel electro self-assembled DNA nanospheres as a drug delivery system for atenolol10.1088/1361-6528/abd727 ↗
51. Synthesis and characterization of DNA fenced, self-assembled SnO2 nano-assemblies for supercapacitor applications10.1039/C5DT04920B ↗
52. Potentiostatic deposition of DNA for scanning probe microscopy10.1016/S0006-3495(92)81961-6 ↗
53. Drug-delivery system based on salmon DNA nano- and micro-scale structures10.1038/s41598-017-09904-9 ↗
54. Salmon milt DNA as a template for the mass production of Ag nanoparticles10.1038/pj.2013.58 ↗
55. DNA/Ag nanoparticles as antibacterial agents against gram-negative bacteria10.3390/nano5010284 ↗
56. Sequence does not matter: the biomedical applications of DNA-based coatings and cores10.3390/ijms222312884 ↗
57. Vinod Kumar Yata · 2021
58. Photocrosslinked DNA nanospheres for drug delivery10.1002/marc.200900872 ↗
59. Probing conformational transitions of polymer chains by microrheology10.1016/j.polymer.2014.05.001 ↗
60. Stabilizing RNA by the sonochemical formation of RNA nanospheres10.1002/smll.201002238 ↗
61. Probing conformational transitions of polymer chains by microrheology10.1016/j.polymer.2014.05.001 ↗
62. Modern biopolymer science
63. Polymers for enhanced oil recovery A paradigm for structure–property relationship in aqueous solution10.1016/j.progpolymsci.2011.05.006 ↗
64. Polydatin encapsulated poly [Lactic-co-glycolic acid] nanoformulation counteract the 7,12-Dimethylbenz[a] anthracene mediated experimental carcinogenesis through the inhibition of cell proliferation
65. Genistein encapsulated inulin-stearic acid bioconjugate nanoparticles: formulation development, characterization and anticancer activity10.1016/j.ijbiomac.2022.02.031 ↗
66. A simple equation for description of solute release II Fickian and anomalous release from swellable devices10.1016/0168-3659(87)90035-6 ↗
67. Fractal kinetics in drug release from finite fractal matrices10.1063/1.1603731 ↗
68. Kinetic modeling on drug release from controlled drug delivery systems
69. On the dilemma of fractal or fractional kinetics in drug release studies: a comparison between Weibull and Mittag-Leffler functions10.1016/j.ijpharm.2018.03.060 ↗
70. Fractional kinetics in drug absorption and disposition processes10.1007/s10928-009-9116-x ↗
71. A Caputo fractional derivative of a function with respect to another function10.1016/j.cnsns.2016.09.006 ↗
72. Gorenflo · 2020